Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Analyst Rating Guide

News

Back

Maravai LifeSciences Q1 2024 Adj EPS $(0.02) Beats $(0.03) Estimate, Sales $64.179M Beat $60.548M Estimate

Author: Benzinga Newsdesk | May 08, 2024 04:22pm

Maravai LifeSciences (NASDAQ:MRVI) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.03) by 33.33 percent. This is a 166.67 percent decrease over earnings of $0.03 per share from the same period last year. The company reported quarterly sales of $64.179 million which beat the analyst consensus estimate of $60.548 million by 6.00 percent. This is a 18.79 percent decrease over sales of $79.025 million the same period last year.

Posted In: MRVI